The purpose of this study is to find targeted therapy for specific gene mutations in metastatic or advanced cancer. You must have progressed on standard of care treatment or have a cancer which has no standard of care treatment. If select mutations are found you may be eligible for a sub-study.
Contact phoneTera Williams | 517.364.2910
Principal investigatorDr. Gordan Srkalovic, MD, PhD